Eltanexor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Eltanexor, covering 2025-03-27 to 2025-12-02. Get the full timeline:
Most recent: Clinical Trial Update: Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]